Le Lézard
Classified in: Science and technology, Business
Subject: LIC

Isoolate and ConnX Partner to Protect Users Working Anywhere and on Any Device


NEW YORK and PLAINSBORO, N.J., Jan. 26, 2021 /PRNewswire-PRWeb/ -- As Advanced Cyber Attacks Grow, Isoolate and ConnX Partner to Protect Users Working Anywhere, over any Network and on Any Device

Isoolate, a leading start-up that is transforming & disrupting the cloud cybersecurity landscape with its advanced web, mobile and threat isolation technologies, today announced they have forged a partnership with ConnX, an AI driven Communications Transformation as a Service platform provider serving enterprises.

The massive, global shift to virtual workforce has accelerated digital transformation strategies and the boundaries of the network perimeter are now inverted. There is no longer a single, defensible boundary between a company's internal assets and the outside world.

This shift is disrupting existing network and security paradigms and businesses need to adapt and adopt new solutions to remain relevant and competitive.

ConnX and Isoolate are teaming up to bring an extremely flexible cybersecurity solution to ConnX clients. Now these enterprises will have access to advanced threat protection on any device, on any network, from anywhere in the world.

"As a leader in AI driven digital communications transformation, ConnX is an ideal technology and business development partner," said Osman Erkan, founder and CEO of Isoolate, a company with a mission to provide advanced threat protection on any device, any network and any location without the complexity and cost associated with legacy solutions by taking a cloud-native approach. "The innovative ConnX team developed ConnX MaestroAI, the industry's first, AI powered, multi-service integrated communications platform. MaestroAI integrates AI WAN, UC collaboration, mobility and security to help enterprise customers reduce operational complexity, provide consistent user experience and critical business insights. MaestroAI enables business intelligence to be actionable, anticipatory, personalized and easy to use."

"ConnX recognized the value and benefits of enhancing the security of its virtual workforce offers by embedding Isoolate's security solution into their AI multi service communications platform. Together, we are making threat protection easy, scalable and affordable, even for the largest enterprise users, who are working remotely on business/personal laptops or mobile phones over home WIFIs or commercial wireless networks. Such users will be as robustly and seamlessly protected from advanced threats as if they were working from within internal trust boundaries."

"Working closely with Isoolate's ready-to-run isolation technologies, ConnX is now able to more effectively address the challenges presented by the new inverted network paradigm associated with today's borderless workforce in cloud native, mobile first applications," said Indrajit Ghosh, CEO, ConnX. "The company's transformational approach delivers excellent user experience with a scalable, cost-efficient, reliable solution that fits in perfectly with our existing managed security portfolio. With Isoolate's solution in our offerings, we're able to secure our customers' everyday communications, even as it continues to evolve in this new era of high-performance remote working."

About Isoolate
Isoolate, founded in 2018 in New York, NY, is transforming the nature of cyber security by liberating users with its application to content driven technology. With its patent pending unique threat isolation technologies, Isoolate seamlessly protects users, from web and SaaS application content borne threats, who work from anywhere, on any device, and over any network. For more information, visit http://www.isoolate.com

About ConnX
ConnX is an AI driven Communications Transformation as a Service platform provider that integrates AI WAN, UC collaboration, mobility and security to help enterprise customers transform from fragmented and siloed communications services to an integrated, AI driven, multi-service collaboration platform. ConnX MaestroAI enables customers to rapidly realize the benefits of AI and digital transformation to mitigate the challenges associated with communications integration, provisioning, support, maintenance, and migration resulting in lower cost, higher productivity and a predictable and consistent user experience. For more information, visit http://www.connxai.com.

Contacts
Selcan Taskiran, CMO; [email protected] ; +1 (437) 238-8969
Anshul Agarwal, Marketing Manager ; [email protected] ; + 1 (609) 955-3030

Media Contact

Selcan Taskiran, Isoolate, 437238969, [email protected]

Anshul Agarwal, ConnX, 6099553030, [email protected]

LinkedIn

 

SOURCE Isoolate


These press releases may also interest you

at 23:00
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

at 22:30
Blue Owl Capital Inc. ("Blue Owl") , a leading alternative asset manager, announced today the hiring of Alicia Gregory as a Managing Director based in Sydney.   Alicia brings over 25 years of investing experience with deep relationships and...

at 22:00
Zetrix Foundation and MY E.G. Services Berhad ("MYEG") signed a Memorandum of Understanding (MoU) with MaiCapital, a licensed virtual asset manager in Hong Kong, to collaborate on the launch of a virtual asset fund or Hong Kong virtual assets...

at 21:38
Grupo Elektra, S.A.B. de C.V. (BMV: ELEKTRA* Latibex: XEKT), Latin America's leading specialty retailer and financial services company, and the largest non-bank provider of...

at 21:30
O2Gold Inc. (NEX: OTGO.H) ("O2Gold" or the "Company") is pleased to announce that it has entered into a share exchange agreement dated March 21, 2024 (the "Agreement") with Quebec Aur Ltd., a private Ontario corporation, (the "Target") and its...

at 21:27
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...



News published on and distributed by: